Correlation Between NovaBay Pharmaceuticals and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both NovaBay Pharmaceuticals and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NovaBay Pharmaceuticals and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NovaBay Pharmaceuticals and Immix Biopharma, you can compare the effects of market volatilities on NovaBay Pharmaceuticals and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NovaBay Pharmaceuticals with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NovaBay Pharmaceuticals and Immix Biopharma.
Diversification Opportunities for NovaBay Pharmaceuticals and Immix Biopharma
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NovaBay and Immix is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding NovaBay Pharmaceuticals and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and NovaBay Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NovaBay Pharmaceuticals are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of NovaBay Pharmaceuticals i.e., NovaBay Pharmaceuticals and Immix Biopharma go up and down completely randomly.
Pair Corralation between NovaBay Pharmaceuticals and Immix Biopharma
Considering the 90-day investment horizon NovaBay Pharmaceuticals is expected to generate 14.73 times less return on investment than Immix Biopharma. But when comparing it to its historical volatility, NovaBay Pharmaceuticals is 1.24 times less risky than Immix Biopharma. It trades about 0.01 of its potential returns per unit of risk. Immix Biopharma is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 164.00 in Immix Biopharma on August 25, 2024 and sell it today you would earn a total of 15.00 from holding Immix Biopharma or generate 9.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NovaBay Pharmaceuticals vs. Immix Biopharma
Performance |
| Timeline |
| NovaBay Pharmaceuticals |
| Immix Biopharma |
NovaBay Pharmaceuticals and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NovaBay Pharmaceuticals and Immix Biopharma
The main advantage of trading using opposite NovaBay Pharmaceuticals and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NovaBay Pharmaceuticals position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| NovaBay Pharmaceuticals vs. Immix Biopharma | NovaBay Pharmaceuticals vs. Cns Pharmaceuticals | NovaBay Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | NovaBay Pharmaceuticals vs. ZyVersa Therapeutics |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |